Neuroscience gets U.S. marketing approval for P-Stim

By Elaine Rigoli

Tampa, Fla., April 12 - Neuroscience Therapy Corp. announced Wednesday that it has received approval from the Food and Drug Administration to begin marketing P-Stim, a miniaturized electro-stimulation device that operates on the principle of ear acupuncture, in the United States.

P-Stim is micro-processor controlled and generates a low frequency electrical pulse, which is transmitted to the peripheral nerve endings in the ear.

This stimulation results in the release of endorphins, the company said.

"I'm very proud of our team for enabling Neuroscience Therapy to get to this point. We are now in an ideal position to begin making revenues in this multi-billion dollar market," president and chief executive officer Randolph A. Turpin said in a news release.

Neuroscience, based in San Dimas, Calif., develops technology to relieve pain.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.